{"id":16545,"date":"2023-05-10T11:06:21","date_gmt":"2023-05-10T15:06:21","guid":{"rendered":"https:\/\/www.med.unc.edu\/neurology\/?p=16545"},"modified":"2023-05-12T12:49:43","modified_gmt":"2023-05-12T16:49:43","slug":"phase-2-study-of-alxn2050-in-generalized-myasthenia-gravis","status":"publish","type":"post","link":"https:\/\/www.med.unc.edu\/neurology\/phase-2-study-of-alxn2050-in-generalized-myasthenia-gravis\/","title":{"rendered":"Phase 2 Study of ALXN2050 in Generalized Myasthenia Gravis"},"content":{"rendered":"<p>A study is being conducted to understand the effectiveness of ALXN2050 compared with placebo in the treatment of generalized MG (gMG) based on improvement in the Myasthenia Gravis Activities of Daily Living (MG-ADL) total score.<\/p>\n<div class=\"uk-first-column\"><hr  style=\"margin:40px 0\"class=\" rule-thin osc-rule\" \/><\/div>\n<div><\/div>\n<div>\n<div class=\"row left-content oscitas-bootstrap-container\">\n<div class=\"col-lg-3 col-md-3 col-xs-12 col-sm-6 oscitas-bootstrap-container\">\n<h4 class=\"uk-margin-remove-bottom\">\u00a0Age &amp; Gender<\/h4>\n<div class=\"uk-padding-small\">\n<ul class=\"uk-list uk-margin-remove\">\n<li>18 years ~ 99 years<\/li>\n<li>Male, Female, Gender Inclusive<\/li>\n<\/ul>\n<\/div>\n<\/div>\n<div class=\"col-lg-3 col-md-3 col-xs-12 col-sm-6 oscitas-bootstrap-container\">\n<h4 class=\"uk-margin-remove-bottom\">Study Interest<\/h4>\n<div class=\"uk-padding-small\">\n<ul class=\"uk-list uk-margin-remove\">\n<li>Brain, Head, and Nervous System<\/li>\n<\/ul>\n<\/div>\n<\/div>\n<div class=\"col-lg-3 col-md-3 col-xs-12 col-sm-6 oscitas-bootstrap-container\">\n<h4 class=\"uk-margin-remove-bottom\">Visit Location<\/h4>\n<div class=\"uk-padding-small\"><a href=\"https:\/\/www.google.com\/maps?q=160+Dental+Cir,+Chapel+Hill,+NC+27514,+USA\">Burnett-Womack Building (UNC-Chapel Hill) | Clinical and Translational Research Center (CTRC)<\/a><\/div>\n<\/div><\/div>\n<hr  style=\"margin:40px 0\"class=\" rule-thin osc-rule\" \/>\n<\/div>\n<p><span style=\"color: #4b9cd3;\"><em><strong>Status: Open<\/strong><\/em><\/span><\/p>\n<div><\/div>\n<div><a class=\"btn btn-primary btn-lg  oscitas-bootstrap-container\" target=\"_self\" href=\"https:\/\/researchforme.unc.edu\/index.php\/en\/study-details?rcid=3869&amp;sdn=411801\">Learn More<\/a><\/div>\n","protected":false},"excerpt":{"rendered":"<p>A study is being conducted to understand the effectiveness of ALXN2050 compared with placebo in the treatment of generalized MG (gMG) based on improvement in the Myasthenia Gravis Activities of Daily Living (MG-ADL) total score. Status: Open<\/p>\n","protected":false},"author":35132,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"layout":"","cellInformation":"","apiCallInformation":"","footnotes":"","_links_to":"","_links_to_target":""},"categories":[103],"tags":[104,113,105,106],"class_list":["post-16545","post","type-post","status-publish","format-standard","hentry","category-clinical-trial-news","tag-brain","tag-general-neurology-and-headache","tag-head","tag-nervous-system","odd"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Phase 2 Study of ALXN2050 in Generalized Myasthenia Gravis | Department of Neurology<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.med.unc.edu\/neurology\/phase-2-study-of-alxn2050-in-generalized-myasthenia-gravis\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Phase 2 Study of ALXN2050 in Generalized Myasthenia Gravis | Department of Neurology\" \/>\n<meta property=\"og:description\" content=\"A study is being conducted to understand the effectiveness of ALXN2050 compared with placebo in the treatment of generalized MG (gMG) based on improvement in the Myasthenia Gravis Activities of Daily Living (MG-ADL) total score. Status: Open\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.med.unc.edu\/neurology\/phase-2-study-of-alxn2050-in-generalized-myasthenia-gravis\/\" \/>\n<meta property=\"og:site_name\" content=\"Department of Neurology\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/UNCNeurology\/\" \/>\n<meta property=\"article:published_time\" content=\"2023-05-10T15:06:21+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-05-12T16:49:43+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@UNCneurology\" \/>\n<meta name=\"twitter:site\" content=\"@UNCneurology\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.med.unc.edu\/neurology\/phase-2-study-of-alxn2050-in-generalized-myasthenia-gravis\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.med.unc.edu\/neurology\/phase-2-study-of-alxn2050-in-generalized-myasthenia-gravis\/\"},\"author\":{\"name\":\"\",\"@id\":\"\"},\"headline\":\"Phase 2 Study of ALXN2050 in Generalized Myasthenia Gravis\",\"datePublished\":\"2023-05-10T15:06:21+00:00\",\"dateModified\":\"2023-05-12T16:49:43+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.med.unc.edu\/neurology\/phase-2-study-of-alxn2050-in-generalized-myasthenia-gravis\/\"},\"wordCount\":127,\"publisher\":{\"@id\":\"https:\/\/www.med.unc.edu\/neurology\/#organization\"},\"keywords\":[\"Brain\",\"General Neurology and Headache\",\"Head\",\"Nervous System\"],\"articleSection\":[\"Clinical Trial News\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.med.unc.edu\/neurology\/phase-2-study-of-alxn2050-in-generalized-myasthenia-gravis\/\",\"url\":\"https:\/\/www.med.unc.edu\/neurology\/phase-2-study-of-alxn2050-in-generalized-myasthenia-gravis\/\",\"name\":\"Phase 2 Study of ALXN2050 in Generalized Myasthenia Gravis | Department of Neurology\",\"isPartOf\":{\"@id\":\"https:\/\/www.med.unc.edu\/neurology\/#website\"},\"datePublished\":\"2023-05-10T15:06:21+00:00\",\"dateModified\":\"2023-05-12T16:49:43+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/www.med.unc.edu\/neurology\/phase-2-study-of-alxn2050-in-generalized-myasthenia-gravis\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.med.unc.edu\/neurology\/phase-2-study-of-alxn2050-in-generalized-myasthenia-gravis\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.med.unc.edu\/neurology\/phase-2-study-of-alxn2050-in-generalized-myasthenia-gravis\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.med.unc.edu\/neurology\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Phase 2 Study of ALXN2050 in Generalized Myasthenia Gravis\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.med.unc.edu\/neurology\/#website\",\"url\":\"https:\/\/www.med.unc.edu\/neurology\/\",\"name\":\"Department of Neurology\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/www.med.unc.edu\/neurology\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.med.unc.edu\/neurology\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.med.unc.edu\/neurology\/#organization\",\"name\":\"UNC Department of Neurology\",\"url\":\"https:\/\/www.med.unc.edu\/neurology\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.med.unc.edu\/neurology\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.med.unc.edu\/neurology\/wp-content\/uploads\/sites\/716\/2018\/05\/new_neurology_logo.jpg\",\"contentUrl\":\"https:\/\/www.med.unc.edu\/neurology\/wp-content\/uploads\/sites\/716\/2018\/05\/new_neurology_logo.jpg\",\"width\":1657,\"height\":601,\"caption\":\"UNC Department of Neurology\"},\"image\":{\"@id\":\"https:\/\/www.med.unc.edu\/neurology\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/UNCNeurology\/\",\"https:\/\/x.com\/UNCneurology\",\"https:\/\/www.instagram.com\/unc_neurology\/\",\"https:\/\/www.linkedin.com\/in\/unc-neurology\/\"]},{\"@type\":\"Person\",\"@id\":\"\",\"url\":\"https:\/\/www.med.unc.edu\/neurology\/author\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Phase 2 Study of ALXN2050 in Generalized Myasthenia Gravis | Department of Neurology","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.med.unc.edu\/neurology\/phase-2-study-of-alxn2050-in-generalized-myasthenia-gravis\/","og_locale":"en_US","og_type":"article","og_title":"Phase 2 Study of ALXN2050 in Generalized Myasthenia Gravis | Department of Neurology","og_description":"A study is being conducted to understand the effectiveness of ALXN2050 compared with placebo in the treatment of generalized MG (gMG) based on improvement in the Myasthenia Gravis Activities of Daily Living (MG-ADL) total score. Status: Open","og_url":"https:\/\/www.med.unc.edu\/neurology\/phase-2-study-of-alxn2050-in-generalized-myasthenia-gravis\/","og_site_name":"Department of Neurology","article_publisher":"https:\/\/www.facebook.com\/UNCNeurology\/","article_published_time":"2023-05-10T15:06:21+00:00","article_modified_time":"2023-05-12T16:49:43+00:00","twitter_card":"summary_large_image","twitter_creator":"@UNCneurology","twitter_site":"@UNCneurology","twitter_misc":{"Written by":"","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.med.unc.edu\/neurology\/phase-2-study-of-alxn2050-in-generalized-myasthenia-gravis\/#article","isPartOf":{"@id":"https:\/\/www.med.unc.edu\/neurology\/phase-2-study-of-alxn2050-in-generalized-myasthenia-gravis\/"},"author":{"name":"","@id":""},"headline":"Phase 2 Study of ALXN2050 in Generalized Myasthenia Gravis","datePublished":"2023-05-10T15:06:21+00:00","dateModified":"2023-05-12T16:49:43+00:00","mainEntityOfPage":{"@id":"https:\/\/www.med.unc.edu\/neurology\/phase-2-study-of-alxn2050-in-generalized-myasthenia-gravis\/"},"wordCount":127,"publisher":{"@id":"https:\/\/www.med.unc.edu\/neurology\/#organization"},"keywords":["Brain","General Neurology and Headache","Head","Nervous System"],"articleSection":["Clinical Trial News"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.med.unc.edu\/neurology\/phase-2-study-of-alxn2050-in-generalized-myasthenia-gravis\/","url":"https:\/\/www.med.unc.edu\/neurology\/phase-2-study-of-alxn2050-in-generalized-myasthenia-gravis\/","name":"Phase 2 Study of ALXN2050 in Generalized Myasthenia Gravis | Department of Neurology","isPartOf":{"@id":"https:\/\/www.med.unc.edu\/neurology\/#website"},"datePublished":"2023-05-10T15:06:21+00:00","dateModified":"2023-05-12T16:49:43+00:00","breadcrumb":{"@id":"https:\/\/www.med.unc.edu\/neurology\/phase-2-study-of-alxn2050-in-generalized-myasthenia-gravis\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.med.unc.edu\/neurology\/phase-2-study-of-alxn2050-in-generalized-myasthenia-gravis\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.med.unc.edu\/neurology\/phase-2-study-of-alxn2050-in-generalized-myasthenia-gravis\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.med.unc.edu\/neurology\/"},{"@type":"ListItem","position":2,"name":"Phase 2 Study of ALXN2050 in Generalized Myasthenia Gravis"}]},{"@type":"WebSite","@id":"https:\/\/www.med.unc.edu\/neurology\/#website","url":"https:\/\/www.med.unc.edu\/neurology\/","name":"Department of Neurology","description":"","publisher":{"@id":"https:\/\/www.med.unc.edu\/neurology\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.med.unc.edu\/neurology\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.med.unc.edu\/neurology\/#organization","name":"UNC Department of Neurology","url":"https:\/\/www.med.unc.edu\/neurology\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.med.unc.edu\/neurology\/#\/schema\/logo\/image\/","url":"https:\/\/www.med.unc.edu\/neurology\/wp-content\/uploads\/sites\/716\/2018\/05\/new_neurology_logo.jpg","contentUrl":"https:\/\/www.med.unc.edu\/neurology\/wp-content\/uploads\/sites\/716\/2018\/05\/new_neurology_logo.jpg","width":1657,"height":601,"caption":"UNC Department of Neurology"},"image":{"@id":"https:\/\/www.med.unc.edu\/neurology\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/UNCNeurology\/","https:\/\/x.com\/UNCneurology","https:\/\/www.instagram.com\/unc_neurology\/","https:\/\/www.linkedin.com\/in\/unc-neurology\/"]},{"@type":"Person","@id":"","url":"https:\/\/www.med.unc.edu\/neurology\/author\/"}]}},"featured_image":false,"featured_image_medium":false,"featured_image_medium_large":false,"featured_image_large":false,"featured_image_thumbnail":false,"featured_image_alt":false,"category_details":[{"name":"Clinical Trial News","link":"https:\/\/www.med.unc.edu\/neurology\/category\/clinical-trial-news\/"}],"tag_details":[{"name":"Brain","link":"https:\/\/www.med.unc.edu\/neurology\/tag\/brain\/"},{"name":"General Neurology and Headache","link":"https:\/\/www.med.unc.edu\/neurology\/tag\/general-neurology-and-headache\/"},{"name":"Head","link":"https:\/\/www.med.unc.edu\/neurology\/tag\/head\/"},{"name":"Nervous System","link":"https:\/\/www.med.unc.edu\/neurology\/tag\/nervous-system\/"}],"_links_to":[],"_links_to_target":[],"_links":{"self":[{"href":"https:\/\/www.med.unc.edu\/neurology\/wp-json\/wp\/v2\/posts\/16545","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.med.unc.edu\/neurology\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.med.unc.edu\/neurology\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.med.unc.edu\/neurology\/wp-json\/wp\/v2\/users\/35132"}],"replies":[{"embeddable":true,"href":"https:\/\/www.med.unc.edu\/neurology\/wp-json\/wp\/v2\/comments?post=16545"}],"version-history":[{"count":0,"href":"https:\/\/www.med.unc.edu\/neurology\/wp-json\/wp\/v2\/posts\/16545\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.med.unc.edu\/neurology\/wp-json\/wp\/v2\/media?parent=16545"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.med.unc.edu\/neurology\/wp-json\/wp\/v2\/categories?post=16545"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.med.unc.edu\/neurology\/wp-json\/wp\/v2\/tags?post=16545"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}